KG vs VRTX · P/E 2.1, rev $34.0M vs P/E 30, rev $3.33B
Kestrel Group, Ltd. (KG) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Kestrel Group, Ltd. (KG) is a insurance - reinsurance company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported KG revenue for 2025-12-31 was $34.0M. Net income was $46.7M. Revenue was up 785.1% from 2024-12-31 to 2025-12-31. KG currently screens at market cap $91.5M and trailing P/E 2.1.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
KG currently screens at market cap $91.5M and trailing P/E 2.1. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the KG and VRTX stock pages for the full models.
Not investment advice.